During a screen of Neisseria gonorrhoeae clinical isolates obtained in Uruguay for susceptibility to azithromycin, we noticed that approximately 10% of the strains examined displayed decreased susceptibility to azithromycin and erythromycin due to the mtr (CDE)-encoded efflux pump system, but remained susceptible to Triton X-100. We now report that the mtr (R) promoter region of one of these isolates contains a dinucleotide insertion (TT) that mediates this resistance phenotype.
Introduction
Azithromycin has been proposed in Uruguay for the treatment of uncomplicated gonococcal infections because of the prevalence of strains of Neisseria gonorrhoeae with clinically significant levels of resistance to penicillin and tetracycline. Antimicrobial susceptibility surveillance studies demonstrated that isolates with decreased azithromycin susceptibility obtained from infected individuals are prevalent. 1 The mtr(CDE)-encoded efflux pump of N. gonorrhoeae mediates an energy-dependent efflux process of structurally diverse hydrophobic agents (HAs) in gonococci. [2] [3] [4] [5] [6] The expression of this system is negatively regulated by the product of the adjacent but divergent mtr(R) gene. 3, 5 The molecular basis for azithromycin resistance in gonococci mediated by the mtr(CDE)-encoded efflux pump has been described recently. 1 We reported previously that a single T:A bp deletion within the mtr(R) promoter region, which would decrease the level of expression of mtr(R), and a missense mutation at codon 45 in the mtr(R)-coding region, frequently occur in strains of gonococci isolated from our patient population. The presence of such mutations explains the decreased azithromycin susceptibility property in clinical isolates with a multiple resistance phenotype (e.g. expression of cross-resistance to erythromycin, Triton X-100 and crystal violet). 1 During the course of our studies, we identified another group of gonococcal isolates that expressed decreased susceptibility to azithromycin and erythromycin because of the mtr(CDE)-encoded efflux pump. Interestingly, these strains remained susceptible to Triton X-100 even though mtr(R) mutations typically result in high levels of gonococcal resistance to Triton X-100.
2,5 DNA sequence analysis of the mtr(R) promoter region of one such strain (9604) revealed that it contained a novel mutation, a double TT insertion within the 13 bp inverted repeated sequence. This dinucleotide insertion increased the spacing between the -10 and -35 hexamers of the mtr(R) promoter from an optimal 17 nucleotides to an unfavourable 19 nucleotides. 1 We now report that this mutation can decrease mtr(R) gene expression in gonococci, resulting in enhanced mtr(CDE) gene expression and decreased bacterial susceptibility to azithromycin and erythromycin without changing susceptibility to other HAs. (Table) . 2, 3 All strains were grown on GC agar base containing glucose and iron supplements at 37ЊC in 3.8% (v/v) CO 2 .
Materials and methods

Strains of N. gonorrhoeae used and growth conditions
Transformation studies and susceptibility testing
Piliated colonies of strain FA19 were transformed to increased resistance to erythromycin with PCR products (see below) of the mtr(R) gene from strain 9604, as described previously. 2 The susceptibilities of the transformants to azithromycin, erythromycin and Triton X-100, were determined along with the parental and the donor strains by the agar dilution method. 1 
PCR amplification and DNA sequencing studies
Chromosomal DNA from strain 9604 was used in PCRs with oligonucleotide primers RPMAL#2 and KH9#3 to amplify the complete mtr(R) gene, which included the promoter region. 6 A PCR product that encompassed the mtr(R) promoter region and the first 200 bp of the mtr(R) coding region was obtained with oligonucleotide primers KH9#3 and KH9#1; the latter primer anneals in the mtr(R) coding region. 6 Purified PCR products were used for the transformation experiments. Automated DNA sequencing on purified PCR products was performed on both DNA strands at the Emory University DNA Sequencing Core Facility.
RNA preparation and RT-PCR
Total RNA from strains FA19, KH15 and LZ6 [a transformant of strain FA19 obtained by transformation with mtr(R) gene from strain 9604] was prepared as described previously. 7 cDNA was synthesized from 500 ng of total RNA. RT-PCRs for the rmp (reduction modifiable protein) gene, which is not controlled by MtrR, 3 were performed as an internal control to assure that equal amounts of RNA were used in the reaction. RNA was reverse transcribed with Superscript II RNase H -reverse transcriptase (Gibco-BRL, Grand Island, NY, USA) using the following primers: rmp-2 (5Ј-GTG TTG GTG ATG ATT GCG TGC C-3Ј), RPMAL#2, 6 mtrD-5 (5Ј-CAA GGA ACA CGG ACA AGA GCG-3Ј), DSD-5 (5Ј-CGG CCA TAA ACA ATG CCC GGC-3Ј) for rmp, mtr(R), mtr(D) and mtr(F) genes, respectively.
Results and discussion
DNA sequence analysis of the complete mtr(R) gene of strain 9604 revealed a wild-type helix-turn-helix (HTH) motif of the MtrR regulatory protein (data not shown) that is necessary for MtrR repression of mtr(CDE) expression. 2, 3, 6 However, downstream of the HTH region we detected the presence of two missense mutations that would cause amino acid replacements at positions 86 (ThrǞAla) and 105 (HisǞTyr) in MtrR. In order to test whether the dinucleotide (TT) insertion in the mtr(R) promoter region was sufficient to cause decreased susceptibility of gonococci to erythromycin and azithromycin, we used PCR products that encompassed either the entire mtr(R) gene (including the promoter region) or the promoter region and the first 200 bp of the mtr(R) coding region in transformation experiments. We found that both PCR products could transform strain FA19 for decreased susceptibility to erythromycin. However, these transformants did not display decreased susceptibility to TX-100 (Table) . The presence of the dinucleotide (TT) insertion in the mtr(R) promoter was confirmed in representative transformants 652 Strain KH15 is a transformant of FA19 that contains a base pair deletion in the 13 bp inverted repeat located within the mtr(R) promoter region.
2,3
Novel mtr(R) mutation and macrolide resistance by DNA sequencing (data not presented), indicating that it was sufficient for mediating the resistance property of strain 9604. Importantly, the level of azithromycin and erythromycin resistance in transformant strain LZ6 was similar to that of the donor strain 9604. In a previous study, we demonstrated that a representative transformant of isolate 9604 bearing an inactivated mtr(C) gene displayed significantly enhanced susceptibility to azithromycin, erythromycin and Triton X-100. 1 Thus, the efflux pump in this strain can recognize all three agents but the relevant mtr(R) mutation provides for enhanced resistance only to the macrolide antibiotics.
The dinucleotide insertion (TT) within the mtr(R) promoter region would increase the spacing between the -10 and -35 promoter hexamers. We hypothesized that this unfavourable distance would reduce the binding of RNA polymerase, and thereby repress and/or reduce transcription of the mtr(R) gene. Accordingly, we compared levels of the mtr(R) transcript by RT-PCR in RNA preparations from isogenic transformants of strain FA19 that contained the double TT insertion (strain LZ6) or a single bp deletion in the mtr(R) promoter (strain KH15). 2 Our results showed that both strains had a decreased level of the mtr(R) transcript compared with parental strain FA19 (Figure, a) . We next examined whether the decreased transcription of mtr(R) observed with strain LZ6 would result in enhanced transcription of the mtr efflux pump protein encoding genes, as was observed previously for transcription of mtr(CDE) in strain KH15. 3 For this purpose we examined the level of the mtr(D) transcript, which encodes the cytoplasmic membrane transporter protein (MtrD) of the mtr efflux pump. 4 We found that in both strains KH15 and LZ6, the level of the mtr(D) transcript was elevated compared with that of strain FA19. Recently, we have identified a fourth protein that appears to be involved in expression of high-level HA resistance mediated by the mtr efflux pump, which is encoded by a gene [mtr(F)] downstream of mtr(R) (W. Veal & W. M. Shafer, manuscript in preparation). As with transcription of mtr(D), the level of mtr(F) transcription was increased in strains KH15 and LZ6 compared with parental strain FA19 (Figure, b) .
The levels of the mtr(D) and mtr(F) transcripts in strains KH15 and LZ6 differed in that those produced by strain FA19 were at a reproducibly higher level. This difference in transcript levels may explain why strain KH15 displays a higher level of resistance to Triton X-100, a non-ionic detergent that is a substrate for the efflux pump. Presumably, the level of mtr(CDE) and mtr(F) expression imparted by the TT insertion in the mtr(R) promoter is sufficient to give enhanced resistance to macrolides but not Triton X-100. In this respect, we have noticed that 10% of the clinical isolates expressing decreased susceptibility to azithromycin (MIC 0.5 mg/L) and erythromycin (MIC 2 mg/L) remain susceptible to Triton X-100 (MIC 125 mg/L). DNA sequencing analysis of one additional strain expressing this phenotype revealed the presence of the TT insertion (data not presented). Our findings suggest that screening of gonococcal clinical isolates for the mtr phenotype based on decreased susceptibility to Triton X-100 may miss strains with mutations such as the TT insertion in the mtr(R) promoter, which produces decreased susceptibility to macrolide antibiotics alone. 
